Insera Therapeutics ‘coming out of stealth mode’ after recent product approval

Sacramento-based Insera Therapeutics Inc. says it's ready to ramp up to commercialization now that it has approval to bring its medical device to Europe.   After nearly a decade developing a device for “minimally-invasive brain surgery” to remove blood clots during a stroke, the company recently received approval from the European Commission for its flagship product, CEO Vikram Janardhan said. “We’re just coming out of stealth mode,” Jan ardhan said, adding that the approval is a major…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news